Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 10/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.39 |
| ▸ | AHR | P35869 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CCND3 | P30281 | 1/20 | 0.38 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8521340 | 0.81 | CYP2D6 (0.43) | RAB9AGAASMN1; SMN2MEN1NPC1 | |
| SCHEMBL11101219 | 0.78 | — | — | |
| SCHEMBL9853987 | 0.77 | RAB9A (0.49) | RAB9AGAASMN1; SMN2MEN1NPC1 | |
| SCHEMBL30170707 | 0.77 | CYP2D6 (0.40) | RAB9AGAASMN1; SMN2MEN1NPC1 | |
| SCHEMBL1325170 | 0.77 | CYP3A4 (0.56) | RAB9AGAASMN1; SMN2MEN1NPC1 | |
| SCHEMBL8608290 | 0.74 | — | — | |
| SCHEMBL520445 | 0.74 | — | — | |
| Ammonia Solution, Strong SCHEMBL28522761 | 0.72 | RAB9A (0.46) | RAB9AGAASMN1; SMN2MEN1NPC1 | |
| Hydrochloric Acid SCHEMBL28479173 | 0.72 | RAB9A (0.46) | RAB9AGAASMN1; SMN2MEN1NPC1 | |
| SCHEMBL21104602 | 0.72 | RAB9A (0.45) | RAB9AGAASMN1; SMN2MEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113540402-B | Internally lithium-philic multi-confinement/induced lithium cathode and preparation method and application thereof | 中南大学 | 2022-10-11 | — | — | CN | claimed |
| WO-2003057687-A1 | METHODS FOR PREPARING DOXORUBICIN DERIVATIVES | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-07-17 | — | — | WO | claimed |
| WO-2003057896-A1 | METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-07-17 | — | — | WO | claimed |
| EP-4435520-B1 | ELECTROSTATIC IMAGE DEVELOPING TONER | FUJIFILM BUSINESS INNOVATION CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-4394516-B1 | TONER FOR DEVELOPING ELECTROSTATIC CHARGE IMAGE, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM BUSINESS INNOVATION CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-4435521-B1 | ELECTROSTATIC IMAGE DEVELOPING TONER | FUJIFILM BUSINESS INNOVATION CORP (JP) | 2026-04-29 | — | — | EP | disclosed |
| US-20260086469-A1 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2026-03-26 | — | — | US | disclosed |
| EP-4715468-A2 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM Business Innovation Corp. (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-20260079415-A1 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2026-03-19 | — | — | US | disclosed |
| EP-4697098-A2 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM Business Innovation Corp. (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-12535749-B2 | Electrostatic charge image developing toner, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2026-01-27 | — | — | US | disclosed |
| US-20040253530-A1 | Image forming method | FUJI XEROX CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| US-20040185367-A1 | Image forming method | FUJI XEROX CO., LTD. (JP) | 2004-09-23 | — | — | US | disclosed |
| US-20040152004-A1 | Toner having specific relation between absorption soectra, and developer, image forming method and image forming apparatus using same | FUJI XEROX CO., LTD. (JP) | 2004-08-05 | — | — | US | disclosed |
| US-6607864-B2 | Heating heating member that is in contact with a toner image to fix toner image onto a recording medium, wherein a surface of heating member or vicinity generates heat, and a toner forming the toner image contains a colorant and binder resin | FUJI XEROX CO., LTD. (JP) | 2003-08-19 | — | — | US | disclosed |
| WO-2003057687-A1 | METHODS FOR PREPARING DOXORUBICIN DERIVATIVES | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-07-17 | — | — | WO | disclosed |
| WO-2003057896-A1 | METHODS FOR PREPARING ANTHRACYCLINONE DERIVATIVES AND ANTHRACYCLINONE DERIVATIVES PER SE | ALBANY MOLECULAR RESEARCH, INC. (US) | 2003-07-17 | — | — | WO | disclosed |
| US-6582867-B2 | A crystalline binder resin and a fatty acid ester or a resin having a contact angle with water that is smaller than that of the crystalline resin; electrography; reproducibility in particle size/distribution; low-temperature fixing; stability | FUJI XEROX CO., LTD. (JP) | 2003-06-24 | — | — | US | disclosed |
| US-20030027073-A1 | Image forming method | FUJI XEROX CO., LTD. (JP) | 2003-02-06 | — | — | US | disclosed |
| US-20020055050-A1 | Toner for developing electrostatic latent image, process for producing the same, and process for forming image | FUJI XEROX CO., LTD. (JP) | 2002-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260079415-A1 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | TAF1, ACIN1, GLRA2 | RAB9A 3071/4885GAA 1323/4885SMN1; SMN2 1231/4885 |
| US-20260086469-A1 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | EWSR1, EZR, TARBP2 | RAB9A 409/4885GAA 1952/4885SMN1; SMN2 1191/4885 |
| US-12535749-B2 | Electrostatic charge image developing toner, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | CECR2, BET1, C1R | RAB9A 703/4885GAA 948/4885SMN1; SMN2 3248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.